Exercise interventions for men with prostate cancer

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 12, 2015, Pages

  Bourke, Liam ^a   Smith, Dianna ^b   Steed, Liz ^b   Hooper, Richard ^b   Catto, James ^c   Albertsen, Peter C ^d   Tombal, Bertrand ^e   Payne, Heather A ^f   Rosario, Derek J ^g  

^a SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

^d UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^e CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^f UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^g UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; PRIORITY JOURNAL; RETRACTED ARTICLE;

EID: 85041740006     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD011251.pub2     Document Type: Article

References (43)

1. Bandura A. Social cognitive theory in cultural context. Applied Psychology: An International Review 2002;51(2):269-90.
2. Baumann FT, Zopf EM, Bloch W. Clinical exercise interventions in prostate cancer patients -a systematic review of randomized controlled trials. Supportive Care in Cancer 2012;20(2):221-33.
3. Beebe-Dimmer JL, Cetin K, Shahinian V, Morgenstern H, Yee C, Schwartz KL, et al. Timing of androgen deprivation therapy use and fracture risk among elderly men with prostate cancer in the United States. Pharmacoepidemiology and Drug Safety 2012;21(1):70-8.
4. Berruti A, Dogliotti L, Bitossi R, Fasolis G, Gorzegno G, Bellina M, et al. Incidence of skeletal complications in patients with bone metastatic prostate cancer and hormone refractory disease: predictive role of bone resorption and formation markers evaluated at baseline. Journal of Urology 2000;164(4):1248-53.
5. Berryman JW. Motion and rest: Galen on exercise and health. Lancet 2012;380(9838):210-1.
6. Bourke L, Kirkbride P, Hooper R, Rosario AJ, Chico TJA, Rosario DJ. Endocrine therapy in prostate cancer: time for reappraisal of risks, benefits and cost-effectiveness?. British Journal of Cancer 2013;108(1):9-13.
7. Bourke L, Homer K, Thaha M, Steed E, Rosario J, Robb K, et al. Interventions for promoting habitual exercise in people living with and beyond cancer. Cochrane Database of Systematic Reviews 2013, Issue 9. [DOI: 10.1002/14651858.CD010192.pub2]
8. Bourke L, Gilbert S, Hooper R, Steed LA, Joshi M, Catto JWF, et al. Lifestyle changes for improving disease-specific quality of life in sedentary men on long-term androgen-deprivation therapy for advanced prostate cancer: a randomised controlled trial. European Urology 2014;65(5):865-72. [DOI: 10.1016/j.eururo.2013.09.040]
9. Carlin BI, Andriole GL. The natural history, skeletal complications, and management of bone metastases in patients with prostate carcinoma. Cancer 2000;88(12 Suppl):2989-94.
10. Carmack Taylor CL, deMoor C, Smith MA, Dunn AL, Basen-Engquist K, Nielsen I, et al. Active for Life After Cancer: a randomized trial examining a lifestyle physical activity program for prostate cancer patients. Psycho-oncology 2006;15(10):847-62.
11. Courneya KS, Friedenreich CM, Quinney HA, Fields AL, Jones LW, Vallance JK, et al. A longitudinal study of exercise barriers in colorectal cancer survivors participating in a randomized controlled trial. Annals of Behavioral Medicine 2005;29(2):147-53.
12. Cramp F, Byron-Daniel J. Exercise for the management of cancer-related fatigue in adults. Cochrane Database of Systematic Reviews 2012, Issue 11. [DOI: 10.1002/14651858.CD006145.pub3]
13. Culos-Reed SN, Robinson JW, Lau H, Stephenson L, Keats M, Norris S, et al. Physical activity for men receiving androgen deprivation therapy for prostate cancer: benefits from a 16-week intervention. Supportive Care in Cancer 2010;18(5):591-9.
14. DiBlasio CJ, Hammett J, Malcolm JB, Judge BA, Womack JH, Kincade MC, et al. Prevalence and predictive factors for the development of de novo psychiatric illness in patients receiving androgen deprivation therapy for prostate cancer. Canadian Journal of Urology 2008;15(5):4249-56.
15. Ficarra V, Novara G, Rosen RC, Artibani W, Carroll PR, Costello A, et al. Systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy. European Urology 2012;62(3):405-17.
16. Galvao DA, Taaffe DR, Spry N, Joseph D, Newton RU. Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial. Journal of Clinical Oncology 2010;28:340-7.
17. Galvão DA, Spry NA, Taaffe DR, Newton RU, Stanley J, Shannon T, et al. Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer. BJU International 2008;102(1):44-7.
18. International Agency for Research on Cancer. Prostate Cancer Estimated Incidence, Mortality and Prevalence Worldwide in 2012. http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx?cancer=prostate (accessed 10 March 2014).
19. Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, Mason MD, et al. Guidelines on Prostate Cancer 2013. European Association of Urology; 2013 March. http://www.uroweb.org/gls/pdf/09_Prostate_Cancer_LR.pdf (accessed 13 March 2014).
20. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane-handbook.org.
21. Kenfield SA, Stampfer MJ, Giovannucci E, Chan JM. Physical activity and survival after prostate cancer diagnosis in the Health Professionals Follow-Up Study. Journal of Clinical Oncology 2011;29(6):726-32.
22. Lane AM, Lovejoy DJ. The effects of exercise on mood changes: the moderating effect of depressed mood. Journal of Sports Medicine and Physical Fitness 2001;41(4):539-45.
23. Levine GN, D'Amico AV, Berger P, Clark PE, Eckel RH, Keating NL, et al. Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology. CA: Cancer Journal for Clinicians 2010;60(3):194-201.
24. Louda M, Valis M, Splichalova J, Pacovsky J, Khaled B, Podhola M, et al. Psychosocial implications and the duality of life outcomes for patients with prostate carcinoma after bilateral orchiectomy. Neuro Endocrinology Letters 2012;33(8):761-4.
25. Michie S, Ashford S, Sniehotta FF, Dombrowski SU, Bishop A, French DP. A refined taxonomy of behaviour change techniques to help people change their physical activity and healthy eating behaviours: the CALO-RE taxonomy. Psychology & Health 2011;26(11):1479-98.
26. Mishra SI, Scherer RW, Geigle PM, Berlanstein DR, Topaloglu O, Gotay CC, et al. Exercise interventions on health-related quality of life for cancer survivors. Cochrane Database of Systematic Reviews 2012, Issue 8. [DOI: 10.1002/14651858.CD007566.pub2]
27. Mishra SI, Scherer RW, Snyder C, Geigle PM, Berlanstein DR, Topaloglu O. Exercise interventions on health-related quality of life for people with cancer during active treatment. Cochrane Database of Systematic Reviews 2012, Issue 8. [DOI: 10.1002/14651858.CD008465.pub2]
28. National Institute for Health and Care Excellence. Behaviour change: the principles for effective interventions. National Institute for Health and Care Excellence; 2007 Oct. NICE public health guidance 6. guidance.nice.org.uk/ph6 (accessed 26 February 2014).
29. Parahoo K, McDonough S, McCaughan E, Noyes J, Semple C, Halstead EJ, et al. Psychosocial interventions for men with prostate cancer. Cochrane Database of Systematic Reviews 2013, Issue 12. [DOI: 10.1002/14651858.CD008529.pub3]
30. Pinkawa M, Gagel B, Piroth MD, Fischedick K, Asadpour B, Kehl M, et al. Erectile dysfunction after external beam radiotherapy for prostate cancer. European Urology 2009;55(1):227-34.
31. Resnick MJ, Koyama T, Fan K-H, Albertsen PC, Goodman M, Hamilton AS, et al. Long-term functional outcomes after treatment for localized prostate cancer. New England Journal of Medicine 2013;368(5):436-45.
32. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
33. Richman EL, Kenfield SA, Stampfer MJ, Paciorek A, Carroll PR, Chan JM. Physical activity after diagnosis and risk of prostate cancer progression: data from the Cancer of the Prostate Strategic Urologic Research Endeavour. Cancer Research 2011;71(11):3889-95.
34. Rogers LQ, Courneya KS, Shah P, Dunnington G, Hopkins-Price P. Exercise stage of change, barriers, expectations, values and preferences among breast cancer patients during treatment: a pilot study. European Journal of Cancer Care 2007;16(1):55-66.
35. Scher HI, Fizazi K, Saad F, Taplin M-E, Sternberg CN, Miller K, et al. Increased survival with enzalutamide in prostate cancer after chemotherapy. New England Journal of Medicine 2012;367(13):1187-97.
36. Segal RJ, Reid RD, Courneya KS, Malone SC, Parliament MB, Scott CG, et al. Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. Journal of Clinical Oncology 2003;21(9):1653-9.
37. Segal RJ, Reid RD, Courneya KS, Sigal RJ, Kenny GP, Prud'Homme DG, et al. Randomized controlled trial of resistance or aerobic exercise in men receiving radiation therapy for prostate cancer. Journal of Clinical Oncology 2009;27(3):344-51.
38. Soerjomataram I, Lortet-Tieulent J, Parkin DM, Ferlay J, Mathers C, Forman D, et al. Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions. Lancet 2012;380(9856):1840-50.
39. Spark LC, Reeves MM, Fjeldsoe BS, Eakin EG. Physical activity and/or dietary interventions in breast cancer survivors: a systematic review of the maintenance of outcomes. Journal of Cancer Survivorship 2013;7(1):74-82.
40. StataCorp. Stata Statistical Software: Release 12. College Station, Texas: StataCorp LP, 2011.
41. Storey DJ, McLaren DB, Atkinson MA, Butcher I, Frew LC, Smyth JF, et al. Clinically relevant fatigue in men with hormone-sensitive prostate cancer on long-term androgen deprivation therapy. Annals of Oncology 2012;23(6):1542-9.
42. Thomas BC, Neal DE. Androgen deprivation treatment in prostate cancer. BMJ (Clinical Research Ed.) 2013;346:e8555.
43. Winter EM, Fowler N. Exercise defined and quantified according to the Système International d'Unités. Journal of Sports Sciences 2009;27(5):447-60.